| Schedule of basic and diluted net loss per share attributable to common stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
|
|
|
|
2018
|
|
2017
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(20,594)
|
|
$
|
(12,439)
|
|
|
Accretion of preferred stock to redemption value
|
|
|
(40,039)
|
|
|
(11,647)
|
|
|
Net loss attributable to common stockholders
|
|
$
|
(60,633)
|
|
$
|
(24,086)
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
Weighted-average number of common shares outstanding—basic and diluted
|
|
|
11,264,252
|
|
|
10,039,592
|
|
|
Net loss per share attributable to common stockholders—basic and diluted
|
|
$
|
(5.38)
|
|
$
|
(2.40)
|
|
|
| Schedule of potential common shares excluded from computation of diluted net loss per share |
|
|
|
|
|
|
|
|
|
|
As of March 31,
|
|
|
|
|
2018
|
|
2017
|
|
|
Options to purchase common stock
|
|
15,368,789
|
|
13,295,581
|
|
|
Unvested restricted stock units
|
|
394,500
|
|
—
|
|
|
Options to purchase Series E-1 preferred stock (as converted to common stock)
|
|
837,835
|
|
837,835
|
|
|
Warrants to purchase common stock
|
|
106,250
|
|
106,250
|
|
|
Warrants to purchase redeemable convertible preferred stock (as converted to common stock)
|
|
167,500
|
|
202,628
|
|
|
Redeemable convertible preferred stock (as converted to common stock)
|
|
44,370,560
|
|
44,225,108
|
|
|
|
|
61,245,434
|
|
58,667,402
|
|
|